NPA today responded to the United States Drug Enforcement Agency’s (DEA) decision to add kratom and mitragynine to its list of schedule I drugs.
NPA submitted a formal request to the Food and Drug Administration (FDA) for an extension of the comment period by 30 days regarding the opportunity for stakeholder comment on the newly released guidance re-draft for New Dietary Ingredient Notifications.
The updated requirements to make GRAS conclusions have widespread implications for the conventional food and dietary supplement industry.
NPA has announced that the much anticipated New Dietary Ingredient (NDI) Guidance will be released this month and most likely tomorrow.
NPA added 59 new members to its ranks in 2016, following up on last year’s strong membership expansion.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.